Michael Luggen, M.D.

Cincinnati Rheumatic Disease Study GroupCincinnati, Ohio - 45219 |
- CLINICAL TRIALS 1
- CONDITIONS2
- INTERVENTIONS1
- SINCE2010

A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Subjects With Systemic Lupus Erythematosus or Myositis
August 2010 - January 2014
Lupus Erythematosus, Systemic
Myositis
Sifalimumab



